fundvisualizer.com

Vanguard PRIMECAP Core InvVPCCX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
81.88%
Non-U.S. Stock
14.97%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.15%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

1.65%

Consumer cyclical

7.88%

Financial services

9.06%

Real estate

0.07%

Consumer defensive

1.13%

Health care

27.97%

Utilities

0.00%

Communication services

5.27%

Energy

3.22%

Industrials

14.46%

Technology

26.14%

Top 10 holdings

As of 12/31/2023

Eli Lilly and Co
8.99%
Intel Corp
3.28%
Amgen Inc
3.18%
Mktliq 12/31/2049
3.16%
AstraZeneca PLC ADR
3.14%
Microsoft Corp
3.07%
Biogen Inc
2.74%
KLA Corp
2.71%
Siemens AG
2.35%
Flex Ltd
2.14%
Fund assets

$13.19 Billion

Share class

Inv

Morningstar category

Large Blend

Expense ratio

0.46%

Investment objective

Growth

Documents